The Relative Strength (RS) Rating for Universal Health Cl B climbed into a new percentile Friday, as it got a lift from 65 to 76.
IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the best-performing stocks typically have an 80 or higher RS Rating in the early stages of their moves. See if Universal Health Cl B can continue to show renewed price strength and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Universal Health Cl B is building a consolidation with a 243.25 entry. See if it can clear the breakout price in volume at least 40% higher than normal.
Universal Health Cl B reported 57% EPS growth in its most recent report. Revenue increased 11%. Keep an eye out for the company's next round of numbers on or around Apr. 28.
The company earns the No. 1 rank among its peers in the Medical-Hospitals industry group. Tenet Healthcare and Nutex Health are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
